Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BRUNDHA BALARAMAN

Allopathic & Osteopathic Physicians Dermatology

NPI
1437461258
CMS profile
1172879
Location
SUGAR LAND, TX

General Payments · PY2018–2024

$13,544.51

  • Reported across 469 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$966.57

56 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $966.57 56

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Janssen Biotech, Inc. $364.54 18
Dermavant Sciences, Inc. $134.99 16
GENZYME CORPORATION $84.67 5
Amgen Inc. $64.01 3
Regeneron Healthcare Solutions, Inc. $61.83 3
Arcutis Biotherapeutics, Inc. $58.06 3
Sensus Healthcare, Inc. $55.47 1
UCB, Inc. $54.01 3
Incyte Corporation $27.47 1
ABBVIE INC. $24.68 1
LEO Pharma Inc. $20.19 1
PFIZER INC. $16.65 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,054.78 38
PY2019 $5,738.99 59
PY2020 $634.09 31
PY2021 $1,095.76 66
PY2022 $2,804.51 144
PY2023 $1,249.81 75
PY2024 $966.57 56

Payment records · PY2024 (56)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $24.68 06/12/2024 Food and Beverage Undisputed 01/23/2026 1103270557 CMS
Amgen Inc. $28.89 01/22/2024 Food and Beverage Undisputed 01/23/2026 1117196431 CMS
Amgen Inc. $19.35 04/09/2024 Food and Beverage Undisputed 01/23/2026 1117196434 CMS
Amgen Inc. $15.77 06/06/2024 Food and Beverage Undisputed 01/23/2026 1117196439 CMS
Arcutis Biotherapeutics, Inc. $20.18 09/18/2024 Food and Beverage Undisputed 01/23/2026 1121038332 CMS
Arcutis Biotherapeutics, Inc. $17.36 10/30/2024 Food and Beverage Undisputed 01/23/2026 1121038334 CMS
Arcutis Biotherapeutics, Inc. $20.52 12/03/2024 Food and Beverage Undisputed 01/23/2026 1121038336 CMS
Dermavant Sciences, Inc. $21.21 01/23/2024 Food and Beverage Undisputed 01/23/2026 1127850010 CMS
Dermavant Sciences, Inc. $15.03 02/23/2024 Food and Beverage Undisputed 01/23/2026 1127850012 CMS
Dermavant Sciences, Inc. $7.47 02/23/2024 Food and Beverage Undisputed 01/23/2026 1127850014 CMS
Dermavant Sciences, Inc. $10.52 03/20/2024 Food and Beverage Undisputed 01/23/2026 1127850016 CMS
Dermavant Sciences, Inc. $9.28 03/21/2024 Food and Beverage Undisputed 01/23/2026 1127850018 CMS
Dermavant Sciences, Inc. $5.74 04/04/2024 Food and Beverage Undisputed 01/23/2026 1127850020 CMS
Dermavant Sciences, Inc. $4.95 04/25/2024 Food and Beverage Undisputed 01/23/2026 1127850022 CMS
Dermavant Sciences, Inc. $10.95 04/26/2024 Food and Beverage Undisputed 01/23/2026 1127850024 CMS
Dermavant Sciences, Inc. $8.14 06/05/2024 Food and Beverage Undisputed 01/23/2026 1127850026 CMS
Dermavant Sciences, Inc. $1.58 06/11/2024 Food and Beverage Undisputed 01/23/2026 1127850028 CMS
Dermavant Sciences, Inc. $6.33 07/15/2024 Food and Beverage Undisputed 01/23/2026 1127850030 CMS
Dermavant Sciences, Inc. $4.62 07/22/2024 Food and Beverage Undisputed 01/23/2026 1127850032 CMS
Dermavant Sciences, Inc. $5.62 08/12/2024 Food and Beverage Undisputed 01/23/2026 1127850034 CMS
Dermavant Sciences, Inc. $6.95 08/12/2024 Food and Beverage Undisputed 01/23/2026 1127850036 CMS
Dermavant Sciences, Inc. $9.02 09/12/2024 Food and Beverage Undisputed 01/23/2026 1127850038 CMS
Dermavant Sciences, Inc. $7.58 10/02/2024 Food and Beverage Undisputed 01/23/2026 1127850040 CMS
GENZYME CORPORATION $15.76 05/20/2024 Food and Beverage Undisputed 01/23/2026 1139645230 CMS
GENZYME CORPORATION $17.26 06/05/2024 Food and Beverage Undisputed 01/23/2026 1139645232 CMS
GENZYME CORPORATION $16.97 08/26/2024 Food and Beverage Undisputed 01/23/2026 1139645296 CMS
GENZYME CORPORATION $20.96 10/08/2024 Food and Beverage Undisputed 01/23/2026 1139645314 CMS
GENZYME CORPORATION $13.72 11/05/2024 Food and Beverage Undisputed 01/23/2026 1139645334 CMS
Incyte Corporation $27.47 09/11/2024 Food and Beverage Undisputed 01/23/2026 1141307177 CMS
Janssen Biotech, Inc. $20.66 01/24/2024 Food and Beverage Undisputed 01/23/2026 1078771417 CMS
Janssen Biotech, Inc. $23.17 02/07/2024 Food and Beverage Undisputed 01/23/2026 1078770044 CMS
Janssen Biotech, Inc. $19.16 02/07/2024 Food and Beverage Undisputed 01/23/2026 1078771210 CMS
Janssen Biotech, Inc. $23.81 03/04/2024 Food and Beverage Undisputed 01/23/2026 1078771314 CMS
Janssen Biotech, Inc. $12.62 04/05/2024 Food and Beverage Undisputed 01/23/2026 1078771154 CMS
Janssen Biotech, Inc. $18.32 04/08/2024 Food and Beverage Undisputed 01/23/2026 1078771612 CMS
Janssen Biotech, Inc. $17.12 04/26/2024 Food and Beverage Undisputed 01/23/2026 1078770901 CMS
Janssen Biotech, Inc. $34.87 05/08/2024 Food and Beverage Undisputed 01/23/2026 1078769955 CMS
Janssen Biotech, Inc. $30.04 08/21/2024 Food and Beverage Undisputed 01/23/2026 1078770189 CMS
Janssen Biotech, Inc. $10.74 09/09/2024 Food and Beverage Undisputed 01/23/2026 1078769722 CMS
Janssen Biotech, Inc. $30.22 09/25/2024 Food and Beverage Undisputed 01/23/2026 1078771088 CMS
Janssen Biotech, Inc. $27.63 10/05/2024 Food and Beverage Undisputed 01/23/2026 1078771490 CMS
Janssen Biotech, Inc. $9.06 10/07/2024 Food and Beverage Undisputed 01/23/2026 1078770015 CMS
Janssen Biotech, Inc. $8.69 11/04/2024 Food and Beverage Undisputed 01/23/2026 1078770905 CMS
Janssen Biotech, Inc. $23.54 11/16/2024 Food and Beverage Undisputed 01/23/2026 1078771279 CMS
Janssen Biotech, Inc. $24.53 11/20/2024 Food and Beverage Undisputed 01/23/2026 1078770853 CMS
Janssen Biotech, Inc. $7.63 12/05/2024 Food and Beverage Undisputed 01/23/2026 1078771048 CMS
Janssen Biotech, Inc. $22.73 12/09/2024 Food and Beverage Undisputed 01/23/2026 1078771540 CMS
LEO Pharma Inc. $20.19 07/16/2024 Food and Beverage Undisputed 01/23/2026 1152619583 CMS
PFIZER INC. $16.65 05/30/2024 Food and Beverage Undisputed 01/23/2026 1131811038 CMS
Regeneron Healthcare Solutions, Inc. $16.90 02/21/2024 Food and Beverage Undisputed 01/23/2026 1114004217 CMS
Regeneron Healthcare Solutions, Inc. $17.15 05/06/2024 Food and Beverage Undisputed 01/23/2026 1114004219 CMS
Regeneron Healthcare Solutions, Inc. $27.78 07/10/2024 Food and Beverage Undisputed 01/23/2026 1114004221 CMS
Sensus Healthcare, Inc. $55.47 03/21/2024 Food and Beverage Undisputed 01/23/2026 1111024834 CMS
UCB, Inc. $17.87 10/02/2024 Food and Beverage Undisputed 01/23/2026 1143411188 CMS
UCB, Inc. $18.37 10/02/2024 Food and Beverage Undisputed 01/23/2026 1143411193 CMS
UCB, Inc. $17.77 12/10/2024 Food and Beverage Undisputed 01/23/2026 1143411197 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.